Myomo Inc (NYSEAMERICAN:MYO) had a decrease of its shares shorted by 6.82%. FINRA announced in March MYO’s total 508,100 shares shorted. The 545,300 previous shares are down with 6.82%. 4 days will cost MYO with 137,500 average volume to recover its former position.

Ticker’s shares touched $1.3 during the last trading session after 8.33% change.Myomo, Inc. is downtrending after having declined 73.43% since March 10, 2018. MYO has 310,550 volume or 225.09% up from normal. MYO underperformed by 77.80% the S&P 500.

Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States.The company has $22.21 million market cap. The firm develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits.Currently it has negative earnings.

For more Myomo, Inc. (NYSEAMERICAN:MYO) news released briefly go to: Businesswire.com, Businesswire.com, Businesswire.com, Businesswire.com or Businesswire.com. The titles are as follows: “Myomo? to Present at Noble Capital Markets’ 15th Annual Investor Conference – Business Wire” released on January 17, 2019, “Myomo Announces Third Quarter 2018 Financial Results – Business Wire” on November 05, 2018, “Myomo and GRE to Conduct Screening Days in Ohio and Detroit – Business Wire” with a publish date: February 14, 2018, “Standard Diversified Announces New Listing on the NYSE American Exchange – Business Wire” and the last “Myomo to Report Fourth Quarter and Year End 2017 Results on March 7, 2018 – Business Wire” with publication date: February 28, 2018.